Mounjaro: A Revolutionary Medication for Type 2 Diabetes and Obesity
Introduction to Mounjaro Mounjaro, a medication developed by Eli Lilly and Company, is rapidly gaining attention as a groundbreaking solution for those living with type 2 diabetes and obesity. Its active ingredient, tirzepatide, is a once-weekly injectable medication designed to help patients manage their blood sugar levels and, in some cases, support weight loss. Approved by the U.S. Food and Drug Administration (FDA), Mounjaro is a game-changer in the treatment of these common chronic conditions. How Mounjaro Works Mounjaro belongs to a class of drugs known as GLP-1 and GIP receptor agonists. It works by activating both the GLP-1 and GIP receptors in the body, which play key roles in regulating blood sugar and appetite. GLP-1 Receptor Agonist : GLP-1 helps to regulate blood sugar by stimulating insulin production and suppressing glucagon (a hormone that raises blood sugar). It also slows gastric emptying, which helps with appetite control. GIP Receptor Agonist : GIP has a compl...